Key Alzheimer’s drug fails memory test, Eli Lilly shares plunge – USA TODAY


USA TODAY
Key Alzheimer’s drug fails memory test, Eli Lilly shares plunge
USA TODAY
Separately, shares of Juno Therapeutics (JUNO) plunged more than 30% to $20.64 after the Seattle-based biopharmaceutical company issued an announcement that one patient had died and another was not expected to recover from tests of a trial …
Lilly’s drug for Alzheimer’s fails big trial; shares dropReuters
Eli Lilly shares tank after Alzheimer’s drug fails in late-stage trialCNBC
Eli Lilly Alzheimer’s Drug Fails TrialWall Street Journal
Irish Times -Eli Lilly and Company
all 204 news articles >>

Source: shares – Google News

Sharing information is key – Share Dealing Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd